Europe begins testing local gene therapy for cystic fibrosis
Clinical trials of an inhaled gene therapy for cystic fibrosis have been launched in European countries, according to a press release from Imperial College London. The experimental drug, BI 3720931, developed by Boehringer Ingelheim, is a working version of…